The clinical relevance of the F. nucleatum–TLR4–MYD88–autophagy (ULK1 and ATG7)–drug resistance axis has been demonstrated through correlation analysis showing that patients harboring the bacteria have higher expression of autophagy markers and higher CRC recurrence [65]. This evidence concerns the gene MYD88 and colorectal carcinoma.